Loading chat...
KS HB2676
Bill
Status
2/25/2026
Primary Sponsor
Health and Human Services
Click for details
AI Summary
-
Expands pharmacist scope of practice to allow independent initiation of therapy for minor, self-limiting conditions that do not require new diagnoses, including influenza, strep throat, and urinary tract infections under statewide protocols
-
Authorizes pharmacists to dispense a one-time emergency 90-day supply of noncontrolled prescription drugs when no refills remain and continuation of therapy is necessary to prevent interruption of care
-
Requires pharmacists who independently initiate therapy to maintain professional liability insurance ($500,000 per claim/$1,500,000 annual aggregate) and participate in the healthcare stabilization fund, effective January 1, 2028
-
Establishes that the collaborative drug therapy management advisory committee will adopt statewide protocols specifying medications, pharmacist training requirements, documentation standards, and patient notification procedures
-
Designates these amendments as the "pharmacist practice authority act" and takes effect upon publication in the Kansas Register
Legislative Description
Permitting a pharmacist to initiate therapy for certain conditions consistent with the pharmacist's education, training and experience.
Last Action
Senate Hearing: Wednesday, March 11, 2026, 8:30 AM Room 142-S
3/11/2026